DOCSLIB.ORG

Ophthalmology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ophthalmology KALEIDA HEALTH Name ____________________________________ Date ____________________ DELINEATION OF PRIVILEGES – OPHTHALMOLOGY All members of the Department of Ophthalmology at Kaleida Health must have the following Credentials: 1. Successful completion of an ACGME, AOA, Royal College of physicians and surgeons of Canada, or an ACGME equivalent Ophthalmology Residency Program. 2. Must be AMBS Board Certified in Ophthalmology or, if not board certified, must obtain certification within two (2) years from appointment. Maintenance of Board Certification is mandatory for those who have achieved this status. 3. Demonstrate or document requisite training for credentials and requested privileges as indicated below. PLEASE NOTE: Please check the box for each privilege requested. Do not use an arrow or line to make selections. We will return applications that ignore this directive. LEVEL I (CORE) PRIVILEGES Level 1 (core) privileges are Muscle Transposition those able to be performed after successful completion of an accredited residency Repair of iridodialysis program in that core specialty. The removal or restriction of these privileges would Cataract extraction require further investigation as to the individual’s overall ability to practice, but there is no need to delineate these privileges individually. Intraocular lens implantation and removal Repair of wound for flat anterior chamber Admission and Discharge privileges at Kaleida Health facilities to Anterior vitrectomy (including pars plana) include hospital inpatients, ambulatory service center patients and Muscle operation for squint other categories of patient admissions. Astigmatic Keratotomy History and Physical for diagnosis and treatment plan CONJUNCTIVA: EYELIDS: Suture of conjunctiva for laceration Blepharotomy; drainage of eyelid abscess Biopsy Xanthelasma, plastic excision and repair Excision of Lesion Excision of nevus or papilloma Conjunctivoplasty: Lid margin lesion, benign or malignant; block Free graft with conjunctiva excision & plastic repair with graft Free graft with buccal mucous membrane Blepharoplasty for redundant skin or herniation of Flap operation for ulcer, perforation of operative wound orbital fat through orbital septum Repair of symblepharon Canthoplasty LACRIMAL: Plastic restoration of eyebrow by graft Drainage, lacrimal gland abscess, I & D Blepharorraphy, tarsorrhaphy, canthoplasty Drainage, lacrimal sac abscess Lid lacerations, reconstruction and plastic repair Excision, lacrimal gland Ptosis, plastic correction: Excision, lacrimal sac Levator resection/Illif or similar method Catheterization, nasolacrimal duct Entropion or ectropion, plastic repair, muscle or tarsal resection or Plastic repair of severed or lacerated canaliculus imbrication with graft (cicatricial) Dacryocystorhinostomy Temporal artery biopsy Closure, punctum Botulinism Injections Dilation and/or irrigation of punctum or canaliculus Fascia Lata Sling for Ptosis Probing, nasolacrimal duct ORBIT: GLAUCOMA: Orbitotomy; for exploration, abscess, foreign body, tumor or Intraocular surgery for glaucoma, peripheral iridectomy and pseudo-tumor; fracture of orbit with repair; decompression filtering including glaucoma drainage devices and antimetabolites Exenteration or evisceration of orbit Implantation of Glaucoma Drainage Devices Orbital injection of alcohol for pain Antimetabolites (Glaucoma Surgery) GLOBE: LASER SURGERY: Enucleation or evisceration with or without implantation Iridotomy Secondary implantation; plastic restoration of orbital volume Lysis of suture Repair of perforated globe Lysis of adhesions Paracentesis, treatment or diagnosis, aspiration Trabeculoplasty Pterygium, excision Retinal Photocoagulation Curettage and cautery of corneal ulcer Capsulotomy Removal of intraocular foreign body with or without magnet Excision, lesion of iris, malignant or non-malignant Excision, lesion of ciliary body, cyclectomy Ophthalmology 2-2020 Ophthalmology Name:________________________________________________ Page 2 Level II (Core) The following privileges require successful completion of an AUPO Accredited Cornea Fellowship Penetrating Keratoplasty Deep Anterior Lamellar Keratoplasty Endothelial Keratoplasty (DSEK) The above Core privileges are those able to be performed after Requested Granted Not Granted Granted with successful completion of an accredited training program in that core following specialty. The removal or restriction of these privileges would requirements: require further investigation as to the individual’s overall ability to practice, but there is no need to delineate these privileges individually. Level II Core (Fellowship Trained Privileges) Level II (Core) The following privileges require successful completion of an AUPO Accredited Cornea/Refractive Fellowship or completion of post-graduate Refractive surgery Training Refractive Surgery The above Core privileges are those able to be performed after Requested Granted Not Granted Granted with successful completion of an accredited training program in that core following specialty. The removal or restriction of these privileges would requirements: require further investigation as to the individual’s overall ability to practice, but there is no need to delineate these privileges individually. Level II Core (Fellowship Trained Privileges) Level II (Core) The following privileges require successful completion of an AUPO Accredited Retinal – Vitreous Fellowship Repair Of Retinal Detachment Posterior Vitrectomy Laser Endophotocoagulation The above Core privileges are those able to be performed after Requested Granted Not Granted Granted with successful completion of an accredited training program in that core following specialty. The removal or restriction of these privileges would requirements: require further investigation as to the individual’s overall ability to practice, but there is no need to delineate these privileges individually. Level II Core (Fellowship Trained Privileges) Pediatric Level II (Core) The following privileges require successful completion of an AUPO Accredited Pediatric or Cornea Fellowship Penetrating Keratoplasty Deep Anterior Lamellar Keratoplasty (DALK) Endothelial Keratoplasty (DSEK) The above Core privileges are those able to be performed after Requested Granted Not Granted Granted with successful completion of an accredited training program in that core following specialty. The removal or restriction of these privileges would requirements: require further investigation as to the individual’s overall ability to practice, but there is no need to delineate these privileges individually. Level II Core (Fellowship Trained Privileges) Ophtholomology 4-2020 Ophthalmology Name:________________________________________________ Page 3 Pediatric Level II (Core) The following privileges require successful completion of an AUPO Accredited Pediatric or Glaucoma Fellowship Antimetabolites (Glaucoma Surgery) Implantation of Glaucoma Drainage Devices The above Core privileges are those able to be performed after Requested Granted Not Granted Granted with successful completion of an accredited training program in that core following specialty. The removal or restriction of these privileges would requirements: require further investigation as to the individual’s overall ability to practice, but there is no need to delineate these privileges individually. Level II Core (Fellowship Trained Privileges) Pediatric Level II (Core) The following privileges require successful completion of an AUPO Accredited Pediatric or Oculo-Plastic Fellowship Botulinism injections Fascia Lata Sling for Ptosis The above Core privileges are those able to be performed after Requested Granted Not Granted Granted with successful completion of an accredited training program in that core following specialty. The removal or restriction of these privileges would requirements: require further investigation as to the individual’s overall ability to practice, but there is no need to delineate these privileges individually. Level II Core (Fellowship Trained Privileges) Pediatric Level II (Core) The following privileges require successful completion of an AUPO Accredited Pediatric /Strabismus Fellowship Muscle Transposition Glaucoma Under Age 2 Cataract Under Age 1 The above Core privileges are those able to be performed after Requested Granted Not Granted Granted with successful completion of an accredited training program in that core following specialty. The removal or restriction of these privileges would requirements: require further investigation as to the individual’s overall ability to practice, but there is no need to delineate these privileges individually. Level II Core (Fellowship Trained Privileges) Ophtholomology 4-2020 Ophthalmology Name:________________________________________________ Page 4 MODERATE/CONSCIOUS SEDATION 1. Providers seeking privileges in moderate/conscious sedation must complete either the ASA sedation course or Medsimulation course receiving a score of 85% or above and repeat the course every four (4) years, or two (2) years for those with a two (2) year expiration date. 2. Providers must also maintain airway management skills through current completed training and certification in ACLS, ATLS, PALS OR NRP. (For details on course availability and maintenance please review the Moderate/Conscious Sedation document located on our credentialing web page.) With following Requested Granted Not Granted* requirements** (provide Details) KEY *NOT GRANTED DUE TO: **WITH FOLLOWING REQUIREMENTS Provide Details Below
Load more

Recommended publications
  • Summary Benchmarks for Preferred Practice Pattern® Guidelines
    SUMMARY BENCHMARKS FOR PREFERRED PRACTICE PATTERN® GUIDELINES TABLE OF CONTENTS Summary Benchmarks for Preferred Practice Pattern Guidelines Introduction . 1 Glaucoma Primary Open-Angle Glaucoma (Initial Evaluation) . 3 Primary Open-Angle Glaucoma (Follow-up Evaluation) . 5 Primary Open-Angle Glaucoma Suspect (Initial and Follow-up Evaluation) . 6 Primary Angle-Closure Disease (Initial Evaluation and Therapy) . 8 Retina Age-Related Macular Degeneration (Initial and Follow-up Evaluation) . 10 Age-Related Macular Degeneration (Management Recommendations) . 11 Diabetic Retinopathy (Initial and Follow-up Evaluation) . 12 Diabetic Retinopathy (Management Recommendations) . 13 Idiopathic Epiretinal Membrane and Vitreomacular Traction (Initial Evaluation and Therapy) . 14 Idiopathic Macular Hole (Initial Evaluation and Therapy) . 15 Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration (Initial and Follow-up Evaluation) . 17 Retinal and Ophthalmic Artery Occlusions (Initial Evaluation and Therapy) . 18 Retinal Vein Occlusions (Initial Evaluation and Therapy) . 19 Cataract/Anterior Segment Cataract (Initial and Follow-up Evaluation) . 20 Cornea/External Disease Bacterial Keratitis (Initial Evaluation) . 22 Bacterial Keratitis (Management Recommendations) . 23 Blepharitis (Initial and Follow-up Evaluation) . 24 Conjunctivitis (Initial Evaluation) . 25 Conjunctivitis (Management Recommendations) . 26 Corneal Ectasia (Initial Evaluation and Follow-up) . 27 Corneal Edema and Opacification (Initial Evaluation) . 28 Corneal Edema
    [Show full text]
  • Description of Alternative Approaches to Measure and Place a Value on Hospital Products in Seven Oecd Countries
    OECD Health Working Papers No. 56 Description of Alternative Approaches to Measure Luca Lorenzoni, and Place a Value Mark Pearson on Hospital Products in Seven OECD Countries https://dx.doi.org/10.1787/5kgdt91bpq24-en Unclassified DELSA/HEA/WD/HWP(2011)2 Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 14-Apr-2011 ___________________________________________________________________________________________ _____________ English text only DIRECTORATE FOR EMPLOYMENT, LABOUR AND SOCIAL AFFAIRS HEALTH COMMITTEE Unclassified DELSA/HEA/WD/HWP(2011)2 Health Working Papers OECD HEALTH WORKING PAPERS NO. 56 DESCRIPTION OF ALTERNATIVE APPROACHES TO MEASURE AND PLACE A VALUE ON HOSPITAL PRODUCTS IN SEVEN OECD COUNTRIES Luca Lorenzoni and Mark Pearson JEL Classification: H51, I12, and I19 English text only JT03300281 Document complet disponible sur OLIS dans son format d'origine Complete document available on OLIS in its original format DELSA/HEA/WD/HWP(2011)2 DIRECTORATE FOR EMPLOYMENT, LABOUR AND SOCIAL AFFAIRS www.oecd.org/els OECD HEALTH WORKING PAPERS http://www.oecd.org/els/health/workingpapers This series is designed to make available to a wider readership health studies prepared for use within the OECD. Authorship is usually collective, but principal writers are named. The papers are generally available only in their original language – English or French – with a summary in the other. Comment on the series is welcome, and should be sent to the Directorate for Employment, Labour and Social Affairs, 2, rue André-Pascal, 75775 PARIS CEDEX 16, France. The opinions expressed and arguments employed here are the responsibility of the author(s) and do not necessarily reflect those of the OECD.
    [Show full text]
  • Diagnostic Nasal/Sinus Endoscopy, Functional Endoscopic Sinus Surgery (FESS) and Turbinectomy
    Medical Coverage Policy Effective Date ............................................. 7/10/2021 Next Review Date ....................................... 3/15/2022 Coverage Policy Number .................................. 0554 Diagnostic Nasal/Sinus Endoscopy, Functional Endoscopic Sinus Surgery (FESS) and Turbinectomy Table of Contents Related Coverage Resources Overview .............................................................. 1 Balloon Sinus Ostial Dilation for Chronic Sinusitis and Coverage Policy ................................................... 2 Eustachian Tube Dilation General Background ............................................ 3 Drug-Eluting Devices for Use Following Endoscopic Medicare Coverage Determinations .................. 10 Sinus Surgery Coding/Billing Information .................................. 10 Rhinoplasty, Vestibular Stenosis Repair and Septoplasty References ........................................................ 28 INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies. Please note, the terms of a customer’s particular benefit plan document [Group Service Agreement, Evidence
    [Show full text]
  • National Correct Coding Initiative's (Ncci) General
    NATIONAL CORRECT CODING INITIATIVE’S (NCCI) GENERAL CORRESPONDENCE LANGUAGE AND SECTION-SPECIFIC EXAMPLES (FOR NCCI PROCEDURE TO PROCEDURE (PTP) EDITS AND MEDICALLY UNLIKELY EDITS (MUE)) EFFECTIVE: April 1, 2017* *INCLUDES 2017 HCPCS/CPT CODES Current Procedural Terminology (CPT) codes, descriptions and other data only are copyright 2016 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association. Applicable FARS\DFARS Restrictions Apply to Government Use. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for the data contained or not contained herein. TABLE OF CONTENTS Section Page Introduction 5 General Correspondence Language for NCCI PTP Edits and Medically Unlikely Edits (MUEs) Standard preparation/monitoring services for anesthesia 8 HCPCS/CPT procedure code definition 8 CPT Manual or CMS manual coding instruction 8 Mutually exclusive procedures 9 Sequential procedure 9 CPT “Separate procedure” definition 9 More extensive procedure 9 Gender-specific procedures 10 Standards of medical/surgical practice 10 Anesthesia service included in surgical procedure 10 Laboratory panel 10 Deleted/modified edits for NCCI 11 Misuse of column two code with column one code 11 Medically Unlikely Edits (MUE) (Units of Service) 11 Deleted/modified edits
    [Show full text]
  • Retinal Pigment Epithelial Tear Resembling Retinal Tear
    Correspondence 333 References 5University of Washington/Fred Hutchinson 1 Dean WH, Banda L, Kambewa ES, Sherwin JC. Increased Cancer Research Center, Seattle, WA, USA intraocular pressure on the first post-operative day 6Department of Ophthalmology and Visual following sutureless extracapsular cataract surgery in Sciences, The University of Texas Medical Branch, Africa. Eye 2012; 26: 332. Galveston, TX, USA 2 Kim JY, Jo MW, Brauner SC, Ferrufino-Ponce Z, Ali R, 7Ophthalmic Consultants of Boston, Harvard Cremers SL et al. Increased intraocular pressure on the first Medical School, Boston, MA, USA postoperative day following resident-performed cataract E-mail: [email protected] surgery. Eye (Lond) 2011; 25: 929–936. Eye (2012) 26, 332–333; doi:10.1038/eye.2011.274; JY Kim1,2,3, M-W Jo4, SC Brauner3, Z Ferrufino-Ponce5, published online 11 November 2011 R Ali6, SL Cremers3 and BA Henderson7 1Department of Ophthalmology, University of Sir, Ulsan College of Medicine, Asan Medical Center, Retinal pigment epithelial tear resembling retinal Seoul, Republic of Korea tear 2Research Institute for Biomacromolecules, University of Ulsan College of Medicine, Case report Asan Medical Center, Seoul, Republic of Korea A 74-year-old Caucasian female with history of advanced 3Massachusetts Eye and Ear Infirmary, Harvard age-related macular degeneration presented with Medical School, Boston, MA, USA decreased vision in the right eye. The patient was 4Department of Preventive Medicine, University of treated with two ranibizumab injections for choroidal Ulsan College of Medicine, Seoul, Republic of Korea neovascularization 5 months prior without Figure 1 (a) SD-OCT showing RPE defect with overlying intact retina.
    [Show full text]
  • 672 Rapid Development of Visual Field Defects Associated with Vigabatrin Therapy
    Case report The incidence of penetrating injury is thought in part to be due to globe shape, with myopic eyes being at A 64-year-old woman presented to eye casualty with a greater risk. Vohra and Good7 suggest, however, that a second episode of right dacryocystitis. The visual acuity medial canthal approach is the safest, especially in larger was 6/6 bilaterally. She was given a 7 day course of oral globes? This is because of a reduction in the equatorial amoxicillin 500 mg t.d.s. with flucloxacillin 250 mg q.d.s. width to axial length ratio in high degrees of axial and was reviewed when the infection had settled. myopia. Inflammation of the tissues surrounding the Syringing showed patent canaliculi with regurgitation usual landmarks, for example following dacryocystitis, and she was listed for dacryocystorhinostomy (DCR) as in this patient, can alter the anatomy of the injection under local anaesthesia. site and increase the risk of perforation. MeyerS reports In the anaesthetic room the patient was sedated with some success with topical anaesthetic techniques which 2.5 mg of intravenous midazolam. Two drops of would eliminate the risk of penetrating ocular injury. amethocaine were instilled into both eyes. Two puffs of Early diagnosis and treatment of ocular perforations 2% lignocaine spray were applied to the right nasal are essential for a good visual outcome6,9 and therefore passage. A nasal pack of 5% cocaine with adrenaline was there should be a high index of suspicion in those cases placed in the right nasal antrum. A local anaesthetic where the injections are excessively painful, or mixture containing 4 ml of 2% lignocaine with 1:200 000 ineffective, or if there is hypotony of the globe or a adrenaline and 4 ml of 0.75% bupivacaine was decrease in visual acuity.
    [Show full text]
  • Quality of Vision in Eyes with Epiphora Undergoing Lacrimal Passage Intubation
    Quality of Vision in Eyes With Epiphora Undergoing Lacrimal Passage Intubation SHIZUKA KOH, YASUSHI INOUE, SHINTARO OCHI, YOSHIHIRO TAKAI, NAOYUKI MAEDA, AND KOHJI NISHIDA PURPOSE: To investigate visual function and optical PIPHORA, THE MAIN COMPLAINT OF PATIENTS WITH quality in eyes with epiphora undergoing lacrimal passage lacrimal passage obstruction, causes blurred vision, intubation. discomfort, and skin eczema, and may even cause so- E DESIGN: Prospective case series. cial embarrassment. Several studies have assessed the qual- METHODS: Thirty-four eyes of 30 patients with ity of life (QoL) or vision-related QoL of patients suffering lacrimal passage obstruction were enrolled. Before and from lacrimal disorders and the impact of surgical treat- 1 month after lacrimal passage intubation, functional vi- ments on QoL, using a variety of symptom-based question- sual acuity (FVA), higher-order aberrations (HOAs), naires.1–8 According to these studies, epiphora negatively lower tear meniscus, and tear clearance were assessed. affects QoL physically and socially; however, surgical An FVA measurement system was used to examine treatment can improve QoL. Increased tear meniscus changes in continuous visual acuity (VA) over time, owing to inadequate drainage contributes to blurry and visual function parameters such as FVA, visual main- vision.9 However, quality of vision (QoV) has not been tenance ratio, and blink frequency were obtained. fully quantified in eyes with epiphora, and the effects of Sequential ocular HOAs were measured for 10 seconds lacrimal surgery on such eyes are unknown. after the blink using a wavefront sensor. Aberration Dry eye, a clinically significant multifactorial disorder of data were analyzed in the central 4 mm for coma-like, the ocular surface and tear film, may cause visual distur- spherical-like, and total HOAs.
    [Show full text]
  • Anterior Segment Surgery and Complications CATARACT EXTRACTION and INTRAOCULAR LENS IMPLANTATION
    10 Anterior Segment Surgery and Complications CATARACT EXTRACTION AND INTRAOCULAR LENS IMPLANTATION Complications PENETRATING KERATOPLASTY Complications Correction of Astigmatism in a Corneal Graft LAMELLAR KERATOPLASTY SUPERFICIAL KERATECTOMY EXCIMER LASER PHOTOTHERAPEUTIC KERATECTOMY CONJUNCTIVAL FLAP LIMBAL STEM CELL TRANSPLANTATION PTERYGIUM EXCISION AND CONJUNCTIVAL AUTOGRAFT CONJUNCTIVAL AND CORNEAL TUMOR EXCISION CORNEAL PERFORATION SURGERY PERMANENT KERATOPROSTHESIS REFRACTIVE SURGERY Radial Keratotomy Excimer Laser Photorefractive Keratectomy Laser In Situ Keratomileusis CONCLUSION Anterior segment surgery ranges from routine cataract extraction and lens implantation, one of the most common surgical operations in the United States, to rarely performed surgery such as permanent keratoprosthesis. It also encompasses surgery first performed centuries ago, such as rudimentary pterygium excision, to the latest in keratorefractive surgery. CATARACT EXTRACTION AND INTRAOCULAR LENS IMPLANTATION The many reasons for the development of cataracts are discussed in detail in Chapter 8. Most cataracts are acquired, but they can also be congenital. This section focuses primarily on the treatment of acquired cataracts in adults. Cataracts in adults are generally age related, but some lens opacities may result from other causes such as trauma, inflammation, systemic illness such as diabetes, or medications such as corticosteroids. Cataracts generally advance slowly over years but can advance rapidly over months, or even faster in some patients. The primary indication for cataract extraction is diminished vision caused by the cataract, significantly affecting the patient's lifestyle. The exact point at which this hardship occurs depends on the patient. Certain patients require little visual function and may delay cataract surgery for years or indefinitely. Other patients with high visual needs seek cataract surgery with much smaller degrees of visual loss.
    [Show full text]
  • Role of Temporary Tarsorrhaphy Using Super Glue in the Management of Corneal Disorders
    Original Article Role of Temporary Tarsorrhaphy Using Super Glue in the Management of Corneal Disorders Muhammad Moin, Irfan Qayyum, Anwar Ul-Haq Ahmad, Mumtaz Hussain Pak J Ophthalmol 2009, Vol. 25 No. 3 . .. .. See end of article for Purpose: To evaluate the safety and efficacy of temporary tarsorrhaphy using authors affiliations super glue in the management of corneal disorders. … ……………………… Material and Methods: A retrospective chart review of 46 consecutive patients who underwent superglue tarsorrhaphy from June 1997 to June 1998 was Correspondence to: performed. All patients were managed at the Institute of Ophthalmology, Mayo Mohammad Moin hospital, Lahore. This study included patients with painful non healing corneal Department of Ophthalmology ulcers, exposure keratopathy (secondary to moderate proptosis), dry eyes (to Mayo Hospital reduce surface area of evaporation) and post-operative patients with conjunctival Lahore flaps ± scleral grafts (to help take up of the graft). Patients with corneal perforations, endopthalmitis or panophthalmitis were excluded from the study. Temporary tarsorrhaphy was done using super glue technique in which the upper eyelashes were glued to the lower lid skin. The degree of lid closure was calculated according to the pre-existing corneal pathology. Patients were followed up on a weekly basis for one month to check for reduction of pain, improvement of corneal pathology and duration of tarsorrhaphy. Results: There were 50 eyes of 46 patients included in the study who underwent super glue tarsorrhaphy for various corneal pathologies. There were 36 males and 10 female patients with an average age of 40 years (range 10-60 yrs). Thirty two eyes had keratitis (fungal, bacterial, disciform, dendritic), 5 had a persistent epithelial defect, 4 had exposure keratopathy secondary to moderate proptosis, 5 had conjunctival flap alone or combined with a scleral graft and 4 had dry eyes.
    [Show full text]
  • Primary External Dacryocystorhinostomy
    11 Primary External Dacryocystorhinostomy Richard H. Hart, Suzanne Powrie, and Geoffrey E. Rose The watering eye may be the result of excessive tear production, abnor- malities of lid position or movement, lacrimal canalicular pump failure, or obstruction of the outfl ow tract. With external dacryocystorhinos- tomy (DCR), the lacrimal sac is directly incorporated into the lateral wall of the nose, so that the canaliculi drain directly into the nasal cavity. The aims of surgery are twofold: to eliminate fl uid and mucus reten- tion within the lacrimal sac and prevent sac enlargement (as a muco- cele) – the latter leading to intermittent viscous ocular discharge – and to bypass the higher hydraulic resistance of the nasolacrimal duct, thereby increasing tear conductance and aiding the relief of epiphora. Indications for Surgery 1. Primary acquired nasolacrimal duct obstruction 2. Secondary acquired nasolacrimal duct obstruction attributed, for example, to dacryolithiasis, endonasal surgery, infl ammatory nasal or sinus disease, or prior midfacial injury 3. Persistent congenital nasolacrimal duct obstruction, often after unsuccessful probing or intubation of the nasolacrimal duct 4. Functional obstruction of lacrimal outfl ow with decreased tear conductance as a result of: (a) Stenosis, but not occlusion, of the nasolacrimal duct (b) Lacrimal canalicular pump failure from age-related laxity of the lower eyelid, or after facial nerve palsy 5. Acute or chronic dacryocystitis; the former group requiring initial treatment with systemic antibiotics Surgical Principles External DCR should establish a low-resistance drainage pathway between the conjunctival tear sac and the nasal cavity, by conversion of the lacrimal sac into part of the lateral nasal wall.
    [Show full text]
  • Refractive Management/Intervention 2017-2019
    Academy MOC Essentials® Practicing Ophthalmologists Curriculum 2017–2019 Refractive Management/Intervention *** Refractive Management/Intervention 2 © AAO 2017-2019 Practicing Ophthalmologists Curriculum Disclaimer and Limitation of Liability As a service to its members and American Board of Ophthalmology (ABO) diplomates, the American Academy of Ophthalmology has developed the Practicing Ophthalmologists Curriculum (POC) as a tool for members to prepare for the Maintenance of Certification (MOC) -related examinations. The Academy provides this material for educational purposes only. The POC should not be deemed inclusive of all proper methods of care or exclusive of other methods of care reasonably directed at obtaining the best results. The physician must make the ultimate judgment about the propriety of the care of a particular patient in light of all the circumstances presented by that patient. The Academy specifically disclaims any and all liability for injury or other damages of any kind, from negligence or otherwise, for any and all claims that may arise out of the use of any information contained herein. References to certain drugs, instruments, and other products in the POC are made for illustrative purposes only and are not intended to constitute an endorsement of such. Such material may include information on applications that are not considered community standard, that reflect indications not included in approved FDA labeling, or that are approved for use only in restricted research settings. The FDA has stated that it is the responsibility of the physician to determine the FDA status of each drug or device he or she wishes to use, and to use them with appropriate patient consent in compliance with applicable law.
    [Show full text]
  • Accreditation Council for Graduate Medical Education
    Accreditation Council for Graduate Medical Education Ophthalmology Case Logs National Data Report Prepared by: Department of Applications and Data Analysis I. National Resident Statistics Main Table A. This main table provides a national picture of educational experiences. The report is ideal for establishing and assessing national policy related to resident practical experiences. Data is broken out by resident role. B. Descriptive statistics have been carefully chosen to provide the most useful information for judging performance at that national level. i. "Natl Res AVE" - The national average describes the mean number of procedures performed per resident in the nation. ii. "Natl Res STD" - The standard deviation indicates how tightly the scores are clustered around the mean in the set of data. iii. "Natl Res MIN" - The minimum value among procedure counts in the nation. iv. "Natl Res MED" - The median value among procedure counts in the nation. v. "Natl Res MAX" - The maximum value seen among procedure counts in the nation. II. National Benchmark Table for Resident Statistics The table displays selected percentile benchmarks of program averages. For example, a score at the 10th percentile indicates that 10% of residents achieved less than the value while the remaining 90% achieved more than the value. © 2015 Accreditation Council for Graduate Medical Education (ACGME) OPHTHALMOLOGY: NATIONAL RESIDENT REPORT (Main Table) Reporting Period: Total Experience of Residents Completing Programs in 2014-2015 Residency Review Committee for Ophthalmology
    [Show full text]